• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将心房颤动筛查去中心化,以克服 STROKESTOP II 研究中社会人口不平等因素对参与率的影响。

Decentralising atrial fibrillation screening to overcome socio-demographic inequalities in uptake in STROKESTOP II.

机构信息

Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden.

Department of Research and Development, Region Halland, Halmstad, Sweden.

出版信息

J Med Screen. 2021 Mar;28(1):3-9. doi: 10.1177/0969141320908316. Epub 2020 Mar 30.

DOI:10.1177/0969141320908316
PMID:32228146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7905746/
Abstract

OBJECTIVE

In the first STROKESTOP atrial fibrillation screening study, participation was influenced by socio-demographic and geographic factors. To improve uptake in the second study, two screening sites were added, closer to low-income neighbourhoods which had very low participation in the first study. This paper aims to analyse the geographic and socio-demographic disparities in uptake in the second trial and compare the results with the first trial.

METHODS

Inhabitants of the Stockholm region born in 1940 and 1941 were randomised 1:1 to be invited to screening or serve as controls. Medical history, blood samples and single-lead-ECG were collected. Invitee's residential parish was used for geo-mapping analysis of the geographical disparities in participation, using hierarchical Bayes methods. Individual data for participants and non-participants were obtained for the socioeconomic variables: educational level, disposable income, immigrant and marital status.

RESULTS

Higher participation was observed in those with higher education, high income, among non-immigrants and married individuals. Participation between the first and second studies improved significantly, where additional screening sites were introduced. These improvements were generally significant, in each population group according to socio-demographic characteristics.

CONCLUSION

Decentralisation of screening sites in an atrial fibrillation screening program yielded a significantly positive impact on screening uptake. Adding local screening sites in areas with low uptake had beneficial impact on participation across a wide spectrum of socio-demographic groups. Decentralised screening substantially increased the screening uptake in deprived areas.

摘要

目的

在首个 STROKESTOP 心房颤动筛查研究中,参与情况受到社会人口和地理因素的影响。为了在第二项研究中提高参与率,增加了两个更接近低收入社区的筛查点,这些社区在第一项研究中的参与率非常低。本文旨在分析第二项试验中参与率的地理和社会人口差异,并将结果与第一项试验进行比较。

方法

斯德哥尔摩地区 1940 年和 1941 年出生的居民被随机分为 1:1 组,邀请他们参加筛查或作为对照组。收集了病史、血液样本和单导联心电图。利用分层贝叶斯方法,根据居住的教区对参与情况的地理差异进行地理映射分析。对于参与者和非参与者的社会经济变量,获得了个人数据:教育水平、可支配收入、移民和婚姻状况。

结果

在受教育程度较高、收入较高、非移民和已婚人群中,参与率较高。引入额外的筛查点后,第一和第二项研究之间的参与率显著提高。这些改进在根据社会人口特征划分的每个人群组中通常都是显著的。

结论

心房颤动筛查计划中的筛查点分散化对筛查参与率产生了显著的积极影响。在参与率较低的地区增加当地的筛查点对广泛的社会人口群体的参与率产生了有益的影响。分散化筛查大大增加了贫困地区的筛查参与率。

相似文献

1
Decentralising atrial fibrillation screening to overcome socio-demographic inequalities in uptake in STROKESTOP II.将心房颤动筛查去中心化,以克服 STROKESTOP II 研究中社会人口不平等因素对参与率的影响。
J Med Screen. 2021 Mar;28(1):3-9. doi: 10.1177/0969141320908316. Epub 2020 Mar 30.
2
Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.基于人群的房颤筛查接受情况的地理和社会人口学差异:STROKESTOP I研究
Int J Cardiol. 2016 Nov 1;222:430-435. doi: 10.1016/j.ijcard.2016.07.198. Epub 2016 Jul 29.
3
Uptake of atrial fibrillation screening aiming at stroke prevention: geo-mapping of target population and non-participation.以预防中风为目标的心房颤动筛查的接受情况:目标人群的地理定位与未参与情况。
BMC Public Health. 2013 Aug 3;13:715. doi: 10.1186/1471-2458-13-715.
4
Adherence to a handheld device-based atrial fibrillation screening protocol is associated with clinical outcomes.基于手持设备的心房颤动筛查方案的依从性与临床结局相关。
Heart. 2024 Apr 15;110(9):626-634. doi: 10.1136/heartjnl-2023-323522.
5
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial.系统筛查心房颤动(STROKESTOP)的临床结局:一项多中心、平行组、非盲、随机对照试验。
Lancet. 2021 Oct 23;398(10310):1498-1506. doi: 10.1016/S0140-6736(21)01637-8. Epub 2021 Aug 29.
6
Neighbourhood deprivation and hospitalization for atrial fibrillation in Sweden.瑞典邻里剥夺与心房颤动住院治疗。
Europace. 2013 Aug;15(8):1119-27. doi: 10.1093/europace/eut019. Epub 2013 Feb 27.
7
Factors predicting participation and potential yield of screening-detected disease among non-participants in a Swedish population-based atrial fibrillation screening study.预测瑞典基于人群的心房颤动筛查研究中未参与者参与以及筛查发现疾病的潜在获益的因素。
Prev Med. 2022 Nov;164:107284. doi: 10.1016/j.ypmed.2022.107284. Epub 2022 Sep 29.
8
Disparities in cervical screening participation: a comparison of Russian, Somali and Kurdish immigrants with the general Finnish population.参与宫颈癌筛查的差异:俄罗斯、索马里和库尔德移民与芬兰普通人群的比较。
Int J Equity Health. 2018 May 4;17(1):56. doi: 10.1186/s12939-018-0768-2.
9
Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: A population-based case-control study.社会经济和人口统计学因素对参与瑞典宫颈癌筛查计划的影响:基于人群的病例对照研究。
PLoS One. 2018 Jan 10;13(1):e0190171. doi: 10.1371/journal.pone.0190171. eCollection 2018.
10
Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design.使用N末端B型利钠肽前体进行心房颤动的逐步大规模筛查:STROKESTOP II研究设计
Europace. 2017 Feb 1;19(2):297-302. doi: 10.1093/europace/euw319.

引用本文的文献

1
Social drivers in atrial fibrillation occurrence, screening, treatment, and outcomes: systematic-narrative hybrid review.心房颤动发生、筛查、治疗及预后中的社会驱动因素:系统叙述性混合综述
Eur Heart J Suppl. 2024 Jul 31;26(Suppl 4):iv50-iv60. doi: 10.1093/eurheartjsupp/suae073. eCollection 2024 Jul.
2
Examining the continuum of resistance model in two population-based screening studies in Sweden.在瑞典两项基于人群的筛查研究中检验耐药连续性模型。
Prev Med Rep. 2023 Jul 13;35:102317. doi: 10.1016/j.pmedr.2023.102317. eCollection 2023 Oct.
3
Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study.

本文引用的文献

1
Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study.采用 N 端脑利钠肽前体对心房颤动进行逐步大规模筛查:STROKESTOP II 研究。
Europace. 2020 Jan 1;22(1):24-32. doi: 10.1093/europace/euz255.
2
Comprehensive analyses of geographical inequalities in cardiovascular disease incidence and survival: A possible aid to rationalize prevention strategies.心血管疾病发病率和生存率的地理不平等综合分析:为预防策略合理化提供可能的帮助。
Eur J Prev Cardiol. 2019 Nov;26(17):1824-1827. doi: 10.1177/2047487319856940. Epub 2019 Jun 10.
3
Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review.
人群心房颤动筛查的成本效益:STROKESTOP 研究。
Eur Heart J. 2023 Jan 14;44(3):196-204. doi: 10.1093/eurheartj/ehac547.
4
Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: An analysis of health equity based on a randomised trial.粪便免疫化学检测或初次结肠镜检查用于结直肠癌筛查:基于一项随机试验的健康公平性分析。
EClinicalMedicine. 2022 Apr 16;47:101398. doi: 10.1016/j.eclinm.2022.101398. eCollection 2022 May.
5
Facilitating participation in cardiovascular preventive initiatives among people with diabetes: a qualitative study.促进糖尿病患者参与心血管疾病预防倡议:一项定性研究。
BMC Public Health. 2021 Jan 22;21(1):203. doi: 10.1186/s12889-021-10172-6.
6
Large-scale screening studies for atrial fibrillation - is it worth the effort?大规模房颤筛查研究——值得做吗?
J Intern Med. 2021 Apr;289(4):474-492. doi: 10.1111/joim.13217. Epub 2021 Jan 7.
社会经济地位、心房颤动与预后之间的关联:一项系统综述
Expert Rev Cardiovasc Ther. 2018 Nov;16(11):857-873. doi: 10.1080/14779072.2018.1533118. Epub 2018 Oct 15.
4
Screening for Atrial Fibrillation With Electrocardiography: US Preventive Services Task Force Recommendation Statement.心电图筛查心房颤动:美国预防服务工作组推荐声明。
JAMA. 2018 Aug 7;320(5):478-484. doi: 10.1001/jama.2018.10321.
5
Barriers and facilitators to participation in a health check for cardiometabolic diseases in primary care: A systematic review.在初级保健中参与心血管代谢疾病健康检查的障碍和促进因素:系统评价。
Eur J Prev Cardiol. 2018 Aug;25(12):1326-1340. doi: 10.1177/2047487318780751. Epub 2018 Jun 19.
6
Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial.丹麦男性血管疾病人群筛查与干预(VIVA):一项随机对照试验
Lancet. 2017 Nov 18;390(10109):2256-2265. doi: 10.1016/S0140-6736(17)32250-X. Epub 2017 Aug 28.
7
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.心房颤动筛查:AF-SCREEN 国际合作研究报告。
Circulation. 2017 May 9;135(19):1851-1867. doi: 10.1161/CIRCULATIONAHA.116.026693.
8
Atrial fibrillation as a risk factor for cognitive decline and dementia.心房颤动作为认知能力下降和痴呆的危险因素。
Eur Heart J. 2017 Sep 7;38(34):2612-2618. doi: 10.1093/eurheartj/ehx208.
9
Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study.房颤的初始表现为卒中:弗雷明汉心脏研究
Stroke. 2017 Feb;48(2):490-492. doi: 10.1161/STROKEAHA.116.015071. Epub 2017 Jan 12.
10
Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design.使用N末端B型利钠肽前体进行心房颤动的逐步大规模筛查:STROKESTOP II研究设计
Europace. 2017 Feb 1;19(2):297-302. doi: 10.1093/europace/euw319.